Literature DB >> 25892872

Inhibitory effects of emodin, baicalin, schizandrin and berberine on hefA gene: treatment of Helicobacter pylori-induced multidrug resistance.

Yan-Qiang Huang1, Gan-Rong Huang1, Ming-Hui Wu1, Hua-Ying Tang1, Zan-Song Huang1, Xi-Han Zhou1, Wen-Qiang Yu1, Jian-Wei Su1, Xiao-Qiang Mo1, Bing-Pu Chen1, Li-Juan Zhao1, Xiao-Feng Huang1, Hong-Yu Wei1, Lian-Deng Wei1.   

Abstract

AIM: To investigate the inhibitory effects of emodin, baicalin, etc. on the hefA gene of multidrug resistance (MDR) in Helicobacter pylori (H. pylori).
METHODS: The double dilution method was used to screen MDR H. pylori strains and determine the minimum inhibitory concentrations (MICs) of emodin, baicalin, schizandrin, berberine, clarithromycin, metronidazole, tetracycline, amoxicillin and levofloxacin against H. pylori strains. After the screened MDR stains were treated with emodin, baicalin, schizandrin or berberine at a 1/2 MIC concentration for 48 h, changes in MICs of amoxicillin, tetracycline, levofloxacin, metronidazole and clarithromycin were determined. MDR strains with reduced MICs of amoxicillin were selected to detect the hefA mRNA expression by real-time quantitative PCR.
RESULTS: A total of four MDR H. pylori strains were screened. Treatment with emodin, baicalin, schizandrin and berberine significantly decreased the MICs of amoxicillin and tetracycline against some strains, decreased by 1 to 2 times, but did not significantly change the MICs of clarithromycin, levofloxacin, and metronidazole against MDR strains. In the majority of strains with reduced MICs of amoxicillin, hefA mRNA expression was decreased; one-way ANOVA (SPSS 12.0) used for comparative analysis, P < 0.05.
CONCLUSION: Emodin, baicalin, schizandrin and berberine significantly decreased the MICs of amoxicillin and tetracycline against some H. pylori strains, possibly by mechanisms associated with decreasing hefA mRNA expression.

Entities:  

Keywords:  Efflux pump; Helicobacter pylori; Multidrug resistance; Traditional Chinese medicine; hefA

Mesh:

Substances:

Year:  2015        PMID: 25892872      PMCID: PMC4394083          DOI: 10.3748/wjg.v21.i14.4225

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  19 in total

1.  Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report.

Authors:  Peter Malfertheiner; Francis Megraud; Colm A O'Morain; John Atherton; Anthony T R Axon; Franco Bazzoli; Gian Franco Gensini; Javier P Gisbert; David Y Graham; Theodore Rokkas; Emad M El-Omar; Ernst J Kuipers
Journal:  Gut       Date:  2012-05       Impact factor: 23.059

2.  Antibiotics resistance rate of Helicobacter pylori in Bhutan.

Authors:  Ratha-korn Vilaichone; Yoshio Yamaoka; Seiji Shiota; Thawee Ratanachu-ek; Lotay Tshering; Tomohisa Uchida; Toshio Fujioka; Varocha Mahachai
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

3.  [A multicenter study of Chinese patent medicine wenweishu/yangweishu in the treatment of Helicobacter pylori positive patients with chronic gastritis and peptic ulcer].

Authors:  Fu-lian Hu
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2010-01-12

Review 4.  Therapeutic effects of traditional herbal medicine on cerebral ischemia: a perspective of vascular protection.

Authors:  Youngmin Bu; Kyungjin Lee; Hyuk-Sang Jung; Sang-Kwan Moon
Journal:  Chin J Integr Med       Date:  2013-10-30       Impact factor: 1.978

5.  Development of novel nanoparticles shelled with heparin for berberine delivery to treat Helicobacter pylori.

Authors:  Chiung-Hung Chang; Wen-Ying Huang; Chih-Ho Lai; Yuan-Man Hsu; Yi-Hsing Yao; Ting-Yu Chen; Jing-Yan Wu; Shu-Fen Peng; Yu-Hsin Lin
Journal:  Acta Biomater       Date:  2010-09-17       Impact factor: 8.947

6.  [Helicobacter pylori-related diseases].

Authors:  Javier P Gisbert
Journal:  Gastroenterol Hepatol       Date:  2012-09       Impact factor: 2.102

7.  Screening test for anti-Helicobacter pylori activity of traditional Chinese herbal medicines.

Authors:  Feng Ma; Ye Chen; Jing Li; He-Ping Qing; Ji-De Wang; Ya-Li Zhang; Bei-Guo Long; Yang Bai
Journal:  World J Gastroenterol       Date:  2010-11-28       Impact factor: 5.742

8.  [Study of Scutellaria baicalensis and Baicalin against antimicrobial susceptibility of Helicobacter pylori strains in vitro].

Authors:  Jing Wu; Dong Hu; Ke-Xia Wang
Journal:  Zhong Yao Cai       Date:  2008-05

9.  Helicobacter pylori infection in India from a western perspective.

Authors:  Selvi Thirumurthi; David Y Graham
Journal:  Indian J Med Res       Date:  2012-10       Impact factor: 2.375

10.  Detection of A2142C, A2142G, and A2143G Mutations in 23s rRNA Gene Conferring Resistance to Clarithromycin among Helicobacter pylori Isolates in Kerman, Iran.

Authors:  Hamid Abdollahi; Mohammad Savari; Mohammad Javad Zahedi; Sodaif Darvish Moghadam; Mehdi Hayatbakhsh Abasi
Journal:  Iran J Med Sci       Date:  2011-06
View more
  12 in total

Review 1.  Innovative Perspectives of Integrated Chinese Medicine on H. pylori.

Authors:  Hui Ye; Zong-Ming Shi; Yao Chen; Jing Yu; Xue-Zhi Zhang
Journal:  Chin J Integr Med       Date:  2018-06-08       Impact factor: 1.978

2.  Renoprotective effects of emodin against diabetic nephropathy in rat models are mediated via PI3K/Akt/GSK-3β and Bax/caspase-3 signaling pathways.

Authors:  Danqing Jing; Hua Bai; Shinan Yin
Journal:  Exp Ther Med       Date:  2017-09-19       Impact factor: 2.447

3.  Baicalin inhibits biofilm formation, attenuates the quorum sensing-controlled virulence and enhances Pseudomonas aeruginosa clearance in a mouse peritoneal implant infection model.

Authors:  Jing Luo; Biying Dong; Ke Wang; Shuangqi Cai; Tangjuan Liu; Xiaojing Cheng; Danqing Lei; Yanling Chen; Yanan Li; Jinliang Kong; Yiqiang Chen
Journal:  PLoS One       Date:  2017-04-28       Impact factor: 3.240

4.  The Influence of Shuttle-Shape Emodin Nanoparticles on the Streptococcus suis Biofilm.

Authors:  Wenya Ding; Jin Sun; He Lian; Changgeng Xu; Xin Liu; Sidi Zheng; Dong Zhang; Xiaopeng Han; Yanyan Liu; Xueying Chen; Bello O God Spower; Yanhua Li
Journal:  Front Pharmacol       Date:  2018-03-13       Impact factor: 5.810

5.  A randomized, multicenter and noninferiority study of amoxicillin plus berberine vs tetracycline plus furazolidone in quadruple therapy for Helicobacter pylori rescue treatment.

Authors:  Jian Zhang; Chuan Han; Wen Quan Lu; Na Wang; Si Ran Wu; Yong Xi Wang; Jin Ping Ma; Jie Hong Wang; Cheng Hao; Dong Hong Yuan; Na Liu; Yong Quan Shi
Journal:  J Dig Dis       Date:  2020-06-09       Impact factor: 2.325

6.  Chitosan Inhibits Helicobacter pylori Growth and Urease Production and Prevents Its Infection of Human Gastric Carcinoma Cells.

Authors:  Shun-Hsien Chang; Pei-Ling Hsieh; Guo-Jane Tsai
Journal:  Mar Drugs       Date:  2020-10-29       Impact factor: 5.118

Review 7.  A Review of the Role of Flavonoids in Peptic Ulcer (2010-2020).

Authors:  Catarina Serafim; Maria Elaine Araruna; Edvaldo Alves Júnior; Margareth Diniz; Clélia Hiruma-Lima; Leônia Batista
Journal:  Molecules       Date:  2020-11-20       Impact factor: 4.411

Review 8.  Multidrug Efflux Systems in Microaerobic and Anaerobic Bacteria.

Authors:  Zeling Xu; Aixin Yan
Journal:  Antibiotics (Basel)       Date:  2015-08-28

9.  Synthesis and Anticancer Activity of Novel 9-O-Substituted Berberine Derivatives.

Authors:  Viktor Milata; Alexandra Svedova; Zuzana Barbierikova; Eva Holubkova; Ingrid Cipakova; Dana Cholujova; Jana Jakubikova; Miroslav Panik; Sona Jantova; Vlasta Brezova; Lubos Cipak
Journal:  Int J Mol Sci       Date:  2019-05-01       Impact factor: 5.923

Review 10.  The Efficacy of Berberine-Containing Quadruple Therapy on Helicobacter Pylori Eradication in China: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.

Authors:  Qian Hu; Ze Peng; Lingli Li; Xin Zou; Lijun Xu; Jing Gong; Ping Yi
Journal:  Front Pharmacol       Date:  2020-02-04       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.